ClinicalTrials.govpublic full text
The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen
cmv infection or reactivation after allogenic hsct, cmv infection, cmv reactivation, allogenic hsct, gvhd prophylaxis, posttransplant cyclophosphamide (ptcy), cyclosporin a, methotrexate, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888422
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.